News Daily News European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs Shelley Wood December 18, 2018
News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News High-Risk Medical Device Approval Process in Europe Inches Towards Transparency Michael O'Riordan July 20, 2018